UPSC Prelims Practice Questions — Ebola crisis: India-Africa summit postponed
Q1. The postponement of the Fourth India-Africa Forum Summit (IAFS-IV) in 2026 was formally announced from the Indian side by which ministry, in coordination with the African Union?
- A. Ministry of External Affairs
- B. Ministry of Health and Family Welfare
- C. Ministry of Home Affairs
- D. Ministry of Culture
Q2. For IAFS-IV, India's principal continental counterpart and co-host — the body consulted for the postponement and rescheduling — is which one of the following?
- A. African Union Commission
- B. African Development Bank
- C. New Partnership for Africa's Development (NEPAD)
- D. Pan-African Parliament
Q3. The India-Africa Forum Summit (IAFS) is best described as which one of the following?
- A. The apex platform for India-Africa engagement, convening Heads of State/Government of India and Africa in partnership with the African Union
- B. A bilateral free-trade arrangement between India and the African Continental Free Trade Area
- C. A specialised financing agency of the African Union for development projects in India
- D. A United Nations regional forum for South-South cooperation in Africa
Q4. How many editions of the India-Africa Forum Summit had been held before the postponed IAFS-IV?
- A. Two
- B. Three
- C. Four
- D. Five
Q5. The 2026 Ebola (Bundibugyo virus) outbreak in the Democratic Republic of the Congo is centred primarily in which province?
- A. Ituri
- B. North Kivu
- C. Équateur
- D. Tshopo
Q6. With reference to the 2026 Ebola outbreak in DRC and Uganda, consider the following statements. Which of the above is/are NOT correct?
- It is caused by the Bundibugyo species of Ebola virus.
- It is the 17th Ebola outbreak recorded in the Democratic Republic of the Congo since 1976.
- Uganda reported imported cases in its capital, Kampala.
- A vaccine licensed specifically against the Bundibugyo virus is being deployed to contain it.
- A. 1 and 2
- B. 4 only
- C. 2 and 3
- D. 1, 2 and 3
Q7. The formal naming and classification of Ebola viruses into species (e.g., Orthoebolavirus bundibugyoense) is undertaken by which body?
- A. International Committee on Taxonomy of Viruses (ICTV)
- B. WHO IHR Emergency Committee
- C. World Organisation for Animal Health (WOAH)
- D. Africa Centres for Disease Control and Prevention (Africa CDC)
Q8. Ebola and Marburg viruses belong to the family Filoviridae, which is best defined as which one of the following?
- A. A family of filamentous, enveloped, single-stranded negative-sense RNA viruses
- B. A family of double-stranded DNA viruses
- C. A family of retroviruses that integrate into the host genome
- D. A family of single-stranded positive-sense RNA viruses
Q9. Counting the 2026 Ebola (Bundibugyo virus) emergency, how many times has the WHO declared a Public Health Emergency of International Concern (PHEIC) since the International Health Regulations (2005) came into force?
- A. Seven
- B. Eight
- C. Nine
- D. Eleven
Q10. Under the International Health Regulations (2005), the authority to formally declare a Public Health Emergency of International Concern rests solely with which of the following?
- A. The WHO Director-General
- B. The IHR Emergency Committee
- C. The World Health Assembly
- D. The WHO Regional Director for Africa
Q11. Among India's external-affairs institutions, which one is the autonomous think-tank on international relations that had hosted academic events on the sidelines of IAFS-IV (subsequently cancelled)?
- A. Indian Council of World Affairs (ICWA)
- B. Indian Council for Cultural Relations (ICCR)
- C. Research and Information System for Developing Countries (RIS)
- D. Manohar Parrikar Institute for Defence Studies and Analyses (MP-IDSA)
Q12. In the context of India's health diplomacy, 'Vaccine Maitri' refers to which one of the following?
- A. India's initiative to supply and gift COVID-19 vaccines to other countries
- B. India's domestic universal immunisation programme for its own population
- C. The WHO-led global facility for equitable sharing of vaccines
- D. An India-Africa joint venture for local vaccine manufacturing